Cerebral Ataxia Treatment Double vision has improved after Cerebral Ataxia Treatment by Dr Alok Sharma (Neuro Surgeon) in 3 months. 1.Speech is improved, as noticed by relatives fri... By: Neurogen Brain and Spine Institute … Continue reading →

The brain is protected by a barrier of cells that tightly regulates the transport of substances into this organ in order to prevent infection. The essential protective function of this barrier is also a red light for 98% of drug candidates for the treatment of the central nervous system. Today in Angewandte Chemie, scientists at the Institute for Research in Biomedicine (IRB Barcelona) have presented a shuttle able to cross the blood-brain barrier and transport various substances into the brain. The team of chemists at IRB Barcelona is now studying its application for specific medical conditions. Together with clinical researchers, they are preparing treatments for glioblastoma -- the most aggressive brain cancer in adults -- , Friedreich's Ataxia -- a hereditary neurodegenerative disease -- , and a type of paediatric brain cancer. "It is estimated that 20% of humans at some time will need a treatment that targets the brain," explains Meritxell Teixid, associate researcher at IRB Barcelona and leader of this line of investigation, "and for many diseases there are some good candidate drugs but none have the capacity to reach their target and thus there is a subsequent loss of potential. Our shuttle offers a solution to an … Continue reading →

Contact Information Available for logged-in reporters only Newswise BETHESDA, Md., Feb. 5, 2015 /PRNewswire-USNewswire/ -- Carrier screening for inherited genetic disorders is an important part of preconception and prenatal care for the nearly 4 million women who give birth in the US annually. Carrier screening is meant to identify couples at risk for passing on such genetic conditions to their children. While there have been limitations to this approach in the past, new technology in genotyping and genetic sequencing allows for more efficient carrier screening of a greater number of conditions simultaneously. In an important new statement, several of the nation's leading medical societies have collaborated to provide guidance on such advances and their use in reproductive medicine. The American College of Medical Genetics and Genomics (ACMG) along with the American College of Obstetricians and Gynecologists, the National Society of Genetic Counselors, the Society for Maternal-Fetal Medicine and Perinatal Quality Foundation have just released a new Joint Statement on "Expanded Carrier Screening in Reproductive Medicine - Points to Consider" published online ahead of print in Obstetrics & Gynecology ("the Green Journal") in Current Commentary at http://journals.lww.com/greenjournal/toc/publishahead. Anthony R. Gregg, MD, FACOG, FACMG, vice-president, Clinical Genetics of the American College of … Continue reading →

Advanced stem cell treatments instead of surgery - Denver Regenerative Medicine If you're tired of treating a chronic injury with prescription drugs, and you've been told surgery is your next option, there may be a different treatment for you. Dr. Joel Cherdack of... By: Denver Regenerative Medicine … Continue reading →

Neck and Shoulder arthritis two years after stem cell therapy by Harry Adelson, N.D. Steve describes his outcome two years after stem cell therapy for his arthritic neck and shoulder by Dr Harry Adelson http://www.docereclinics.com. By: Harry Adelson, N.D. … Continue reading →

For patients with brain cancer, radiation is a powerful and potentially life-saving treatment, but it can also cause considerable and even permanent injury to the brain. Now, through preclinical experiments conducted in rats, Memorial Sloan Kettering Cancer Center researchers have developed a method to turn human stem cells into cells that are instructed to repair damage in the brain. Rats treated with the human cells regained cognitive and motor functions that were lost after brain irradiation. The findings are reported in the February 5 issue of the journal Cell Stem Cell. During radiation therapy for brain cancer, progenitor cells that later mature to produce the protective myelin coating around neurons are lost or significantly depleted, and there is no treatment available to restore them. These myelinating cells--called oligodendrocytes--are critical for shielding and repairing the brain's neurons throughout life. A team led by neurosurgeon Viviane Tabar, MD, and research associate Jinghua Piao, PhD, of the Memorial Sloan Kettering Cancer Center in New York City, wondered whether stem cells could be coaxed to replace these lost oligodendrocyte progenitor cells. They found that this could be achieved by growing stem cells--either human embryonic stem cells or induced pluripotent stem cells derived from skin … Continue reading →